InsiderClue
← All stocks

Intellia Therapeutics, Inc.

NTLA Net selling
CIK 0001652130 #2130 in the set updated 18 Sep 2026
Bought (120 mo)
$2.52M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$312.27M
$599.20K on a plan · $98.75M straight out of an exercise
Sold at will
$212.92M
114 of 285 sales
Net
−$309.74M
−$210.40M against sales at will

By person

29 insiders · 296 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FORMELA JEAN FRANCOIS
Director
—
$155.43M (46)
−$155.43M
580,667
0.4144%
$7.55M
−75.9%
LEONARD JOHN M
President and CEO
—
$54.97M (59) scheduled
−$54.97M
1,205,479
0.8603%
$15.67M
+129.3%
Novartis Institutes for BioMedical Research, Inc. entity
10% owner
—
$27.87M (1)
−$27.87M
4,129,903
2.95%
$53.69M
−25.9%
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
—
$19.26M (24) scheduled
−$19.26M
77,388
0.0552%
$1.01M
+1,648%
Caribou Biosciences, Inc. entity
10% owner
—
$14.75M (2)
−$14.75M
3,994,355
2.85%
$51.93M
−28.6%
Rivera Jose E
EVP, General Counsel
—
$9.82M (47) scheduled
−$9.82M
686,808
0.4901%
$8.93M
+29.4%
Goddard Glenn
EVP, Chief Financial Officer
—
$8.79M (16) scheduled
−$8.79M
69,213
0.0494%
$899.77K
—
Bermingham Nessan
President & CEO
—
$7.00M (5)
−$7.00M
458,250
0.3270%
$5.96M
−41.7%
KARSEN PERRY A
Director
—
$4.75M (3) scheduled
−$4.75M
5,000
0.0036%
$65.00K
—
Atlas Venture Fund IX, L.P. entity
10% owner
—
$2.44M (3)
−$2.44M
3,579,788
2.55%
$46.54M
−19.2%
Lebwohl David
EVP, Chief Medical Officer
—
$2.37M (21) scheduled
−$2.37M
131,192
0.0936%
$1.71M
+2,466%
Crowley John F
Director
—
$1.60M (6) scheduled
−$1.60M
11,716
0.0084%
$152.31K
—
Cohen Fred E
Director
$1.40M (1)
—
+$1.40M
216,653
0.1546%
$2.82M
—
CHASE WILLIAM J
Director
$1.00M (1)
—
+$1.00M
143,893
0.1027%
$1.87M
+2,016%
Clark Eliana
EVP, Chief Technical Officer
—
$690.37K (15)
−$690.37K
93,864
0.0670%
$1.22M
+849.3%
DORSA CAROLINE
Director
—
$616.40K (3) scheduled
−$616.40K
12,701
0.0091%
$165.11K
—
BASTA JAMES
EVP, General Counsel
—
$499.69K (8)
−$499.69K
156,794
0.1119%
$2.04M
+1,408%
Dulac Edward J III
EVP, Chief Financial Officer
—
$338.80K (4)
−$338.80K
148,175
0.1057%
$1.93M
—
Atlas Venture Associates IX, L.P. entity
10% owner
—
$293.84K (2)
−$293.84K
3,729,788
2.66%
$48.49M
−0.6%
Hicks Derek
EVP, Chief Business Officer
—
$260.84K (3)
−$260.84K
59,878
0.0427%
$778.41K
—
Dube Michael P
VP, Chief Accounting Officer
—
$184.23K (6)
−$184.23K
66,886
0.0477%
$869.52K
+114.2%
Bhanji Muna
Director
—
$95.82K (5) scheduled
−$95.82K
36,403
0.0260%
$473.24K
—
Schultes Birgit C
EVP, Chief Scientific Officer
—
$78.90K (2)
−$78.90K
137,733
0.0983%
$1.79M
+98.3%
SCHIERMEIER ANDREW
EVP, Chief Operating Officer
$117.88K (2)
$76.92K (1)
+$40.96K
16,656
0.0119%
$216.53K
+292.7%
Verwiel Frank
Director
—
$37.63K (1) scheduled
−$37.63K
35,148
0.0251%
$456.92K
—
GOODMAN JESSE
Director
—
$29.07K (2) scheduled
−$29.07K
33,559
0.0239%
$436.27K
—
Keresty Georgia
Director
—
—
—
41,083
0.0293%
$534.08K
—
Goff Brian
Director
—
—
—
32,609
0.0233%
$423.92K
—
Bell Graeme
EVP, Chief Financial Officer
—
—
—
21,400
0.0153%
$278.20K
—

Individual transactions

88
Insider
Date
Role
Action
Shares
Price
Amount
Dulac Edward J III
22 Jul 2026
EVP, Chief Financial Officer
Sell
8,111
$11.25
$91.25K
Dube Michael P
1 Jul 2026
VP, Chief Accounting Officer
Sell
2,641
$16.78
$44.32K
Clark Eliana
2 Mar 2026
EVP, Chief Technical Officer
Sell
607
$13.78
$8.36K
BASTA JAMES
2 Mar 2026
EVP, General Counsel
Sell
1,211
$13.78
$16.69K
Dube Michael P
5 Jan 2026
VP, Chief Accounting Officer
Sell
2,989
$9.21
$27.53K
Dulac Edward J III
5 Jan 2026
EVP, Chief Financial Officer
Sell
6,379
$9.21
$58.75K
Clark Eliana
5 Jan 2026
EVP, Chief Technical Officer
Sell
9,515
$9.21
$87.63K
Lebwohl David
5 Jan 2026
EVP, Chief Medical Officer
Sell
11,903
$9.21
$109.63K
BASTA JAMES
5 Jan 2026
EVP, General Counsel
Sell
10,397
$9.21
$95.76K
Schultes Birgit C
5 Jan 2026
EVP, Chief Scientific Officer
Sell
8,508
$9.21
$78.36K
LEONARD JOHN M
5 Jan 2026
President and CEO
Sell
34,146
$9.21
$314.48K
Dube Michael P
1 Oct 2025
VP, Chief Accounting Officer
Sell
1,871
$17.38
$32.52K
Schultes Birgit C
1 Oct 2025
EVP, Chief Scientific Officer
Sell
31
$17.38
$538.78
Dulac Edward J III
23 Jul 2025
EVP, Chief Financial Officer
Sell
7,462
$14.02
$104.62K
Dube Michael P
2 Jul 2025
VP, Chief Accounting Officer
Sell
2,503
$9.95
$24.90K
Clark Eliana
1 Jul 2025
EVP, Chief Technical Officer
Sell
1,022
$9.82
$10.04K
BASTA JAMES
4 Mar 2025
EVP, General Counsel
Sell
2,572
$8.99
$23.12K
Clark Eliana
4 Mar 2025
EVP, Chief Technical Officer
Sell
679
$8.99
$6.10K
Clark Eliana
3 Jan 2025
EVP, Chief Technical Officer
Sell
7,422
$12.18
$90.40K
Sepp-Lorenzino Laura
3 Jan 2025
EVP, Chief Scientific Officer
Sell
8,966
$12.18
$109.21K
LEONARD JOHN M
3 Jan 2025
President and CEO
Sell
26,807
$12.18
$326.51K
Hicks Derek
3 Jan 2025
EVP, Chief Business Officer
Sell
6,502
$12.18
$79.19K
Lebwohl David
3 Jan 2025
EVP, Chief Medical Officer
Sell
9,557
$12.18
$116.40K
BASTA JAMES
3 Jan 2025
EVP, General Counsel
Sell
7,074
$12.18
$86.16K
Dube Michael P
3 Jan 2025
VP, Chief Accounting Officer
Sell
1,372
$12.18
$16.71K
Clark Eliana
2 Jan 2025
EVP, Chief Technical Officer
Sell
556
$12.03
$6.69K
Dube Michael P
2 Oct 2024
VP, Chief Accounting Officer
Sell
2,012
$19.01
$38.25K
Clark Eliana
1 Jul 2024
EVP, Chief Technical Officer
Sell
405
$22.93
$9.29K
Clark Eliana
4 Mar 2024
EVP, Chief Technical Officer
Sell
605
$32.99
$19.96K
BASTA JAMES
4 Mar 2024
EVP, General Counsel
Sell
2,297
$32.99
$75.78K
Clark Eliana
3 Jan 2024
EVP, Chief Technical Officer
Sell
4,301
$29.46
$126.71K
Clark Eliana
3 Jan 2024
EVP, Chief Technical Officer
Sell
307
$30.12
$9.25K
BASTA JAMES
3 Jan 2024
EVP, General Counsel
Sell
3,805
$29.46
$112.10K
Hicks Derek
3 Jan 2024
EVP, Chief Business Officer
Sell
3,877
$29.46
$114.22K
Goddard Glenn
3 Jan 2024
EVP, Chief Financial Officer
Sell
5,365
$29.46
$158.05K
Sepp-Lorenzino Laura
3 Jan 2024
EVP, Chief Scientific Officer
Sell
5,532
$29.46
$162.97K
Lebwohl David
3 Jan 2024
EVP, Chief Medical Officer
Sell
5,843
$29.46
$172.13K
LEONARD JOHN M
3 Jan 2024
President and CEO
Sell
19,223
$29.46
$566.31K
Clark Eliana
3 Jul 2023
EVP, Chief Technical Officer
Sell
360
$40.51
$14.58K
BASTA JAMES
2 Mar 2023
EVP, General Counsel
Sell
1,088
$43.88
$47.74K
Sepp-Lorenzino Laura
5 Jan 2023
EVP, Chief Scientific Officer
Sell
689
$39.10
$26.94K
Sepp-Lorenzino Laura
5 Jan 2023
EVP, Chief Scientific Officer
Sell
1,641
$38.22
$62.72K
BASTA JAMES
4 Jan 2023
EVP, General Counsel
Sell
1,138
$37.21
$42.34K
Clark Eliana
4 Jan 2023
EVP, Chief Technical Officer
Sell
1,692
$37.21
$62.96K
Goddard Glenn
4 Jan 2023
EVP, Chief Financial Officer
Sell
2,427
$37.21
$90.31K
Lebwohl David
4 Jan 2023
EVP, Chief Medical Officer
Sell
2,574
$37.21
$95.78K
Hicks Derek
4 Jan 2023
EVP, Chief Business Officer
Sell
1,812
$37.21
$67.42K
LEONARD JOHN M
4 Jan 2023
President and CEO
Sell
6,673
$37.21
$248.30K
Sepp-Lorenzino Laura
4 Jan 2023
EVP, Chief Scientific Officer
Sell
2,508
$37.21
$93.32K
Clark Eliana
3 Jan 2023
EVP, Chief Technical Officer
Sell
231
$34.48
$7.96K
Clark Eliana
1 Jul 2022
EVP, Chief Technical Officer
Sell
105
$51.74
$5.43K
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
6,149
$143.45
$882.07K
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
13,556
$142.88
$1.94M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
8,420
$141.66
$1.19M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
8,027
$140.80
$1.13M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
52,320
$139.96
$7.32M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
4,201
$138.58
$582.17K
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
5,400
$138.05
$745.47K
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
3,033
$137.01
$415.55K
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
21,893
$135.83
$2.97M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
30,831
$134.86
$4.16M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
36,519
$133.77
$4.89M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
56,188
$132.77
$7.46M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
53,823
$131.82
$7.09M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
66,468
$130.79
$8.69M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
48,724
$129.88
$6.33M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
56,280
$128.77
$7.25M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
55,525
$127.79
$7.10M
FORMELA JEAN FRANCOIS
28 Jun 2021
Director
Sell indirect
26,019
$127.02
$3.30M
FORMELA JEAN FRANCOIS
14 Jun 2021
Director
Sell indirect
653
$89.25
$58.28K
FORMELA JEAN FRANCOIS
14 Jun 2021
Director
Sell indirect
13,309
$88.70
$1.18M
FORMELA JEAN FRANCOIS
14 Jun 2021
Director
Sell indirect
93,102
$87.75
$8.17M
FORMELA JEAN FRANCOIS
14 Jun 2021
Director
Sell indirect
47,422
$86.73
$4.11M
FORMELA JEAN FRANCOIS
14 Jun 2021
Director
Sell indirect
16,293
$85.92
$1.40M
FORMELA JEAN FRANCOIS
11 Jun 2021
Director
Sell indirect
1,875
$85.98
$161.21K
FORMELA JEAN FRANCOIS
11 Jun 2021
Director
Sell indirect
29,071
$85.18
$2.48M
FORMELA JEAN FRANCOIS
29 Apr 2021
Director
Sell indirect
4,513
$85.43
$385.55K
FORMELA JEAN FRANCOIS
28 Apr 2021
Director
Sell indirect
29,740
$86.12
$2.56M
FORMELA JEAN FRANCOIS
28 Apr 2021
Director
Sell indirect
102,186
$85.40
$8.73M
FORMELA JEAN FRANCOIS
27 Apr 2021
Director
Sell indirect
61,680
$87.08
$5.37M
FORMELA JEAN FRANCOIS
27 Apr 2021
Director
Sell indirect
68,836
$86.41
$5.95M
FORMELA JEAN FRANCOIS
27 Apr 2021
Director
Sell indirect
79,714
$85.39
$6.81M
FORMELA JEAN FRANCOIS
26 Apr 2021
Director
Sell indirect
806
$84.93
$68.45K
FORMELA JEAN FRANCOIS
5 Apr 2021
Director
Sell indirect
800
$84.98
$67.98K
FORMELA JEAN FRANCOIS
26 Feb 2021
Director
Sell indirect
501,945
$60.29
$30.26M
Rivera Jose E
5 Jan 2021
EVP, General Counsel
Sell
2,078
$55.86
$116.08K
SCHIERMEIER ANDREW
5 Jan 2021
EVP, Chief Operating Officer
Sell
1,377
$55.86
$76.92K
LEONARD JOHN M
5 Jan 2021
President and CEO
Sell
6,239
$55.86
$348.51K
Showing 250 of 296 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 286
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 158
Sales at will 114
Transactions with no price 1
Shares from compensation/vesting 4,270,370
Sales filed before the plan box existed 75
History held since 5 Jan 2017